Back to Search Start Over

Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles.

Authors :
Bernard Q
Goumeidane M
Chaumond E
Robbe-Saule M
Boucaud Y
Esnault L
Croué A
Jullien J
Marsollier L
Marion E
Source :
PLoS pathogens [PLoS Pathog] 2023 Jul 10; Vol. 19 (7), pp. e1011479. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Publication Year :
2023

Abstract

Buruli ulcer is a chronic infectious disease caused by Mycobacterium ulcerans. The pathogen persistence in host skin is associated with the development of ulcerative and necrotic lesions leading to permanent disabilities in most patients. However, few of diagnosed cases are thought to resolve through an unknown self-healing process. Using in vitro and in vivo mouse models and M. ulcerans purified vesicles and mycolactone, we showed that the development of an innate immune tolerance was only specific to macrophages from mice able to heal spontaneously. This tolerance mechanism depends on a type I interferon response and can be induced by interferon beta. A type I interferon signature was further detected during in vivo infection in mice as well as in skin samples from patients under antibiotics regiment. Our results indicate that type I interferon-related genes expressed in macrophages may promote tolerance and healing during infection with skin damaging pathogen.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright: © 2023 Bernard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Details

Language :
English
ISSN :
1553-7374
Volume :
19
Issue :
7
Database :
MEDLINE
Journal :
PLoS pathogens
Publication Type :
Academic Journal
Accession number :
37428812
Full Text :
https://doi.org/10.1371/journal.ppat.1011479